AbCellera Biologics Inc. (ABCL)
Market Closed
17 Jul, 20:00
$
6. 46
+0.3
+4.9513%
Pre Market
$
-0.01 -0.232% 6. 45
2.06B Market Cap
- P/E Ratio
- Div Yield
4.23M Volume
-0.47 Eps
$ 6.16
Previous Close 
Want to track ABCL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AbCellera Biologics Inc. (ABCL) Statistics
Valuation metrics
Market Cap 2.06B
Enterprise value 2.04B
Trailing P/E (ttm) -13.47
Forward P/E -
PEG ratio -0.86
Price/Sales (ttm) 24.93
Price/Book (mrq) 2.09
Enterprise Value/Revenue 25.72
Enterprise Value/EBITDA -12.93
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 5.8M
Average volume (90 days) 8.03M
Price summary
52-Week low 2.75
52-Week high 8.44
Beta -
50-Day moving average 6.57
200-Day moving average 4.26
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.82%
Operating margin -2.68%
Operational effectiveness
Return on assets -0.11%
Return on equity -0.15%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.26
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.47
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.67
Total debt (mrq) -
Total Debt/Equity (mrq) 0.15
Current ratio (mrq) 14.05%
Book value per share (mrq) 3.1
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
